$2.21
5.56%
Nasdaq, Thu, Jul 24 2025
ISIN
US68620A1043
Symbol
ONVO

Organovo Holdings, Inc. Stock price

$2.21
+0.68 43.97% 1M
-1.89 46.15% 6M
-3.31 59.96% YTD
-4.57 67.40% 1Y
-34.03 93.90% 3Y
-158.64 98.63% 5Y
-830.59 99.73% 10Y
-3.46 60.99% 20Y
Nasdaq, Closing price Thu, Jul 24 2025
-0.13 5.56%
ISIN
US68620A1043
Symbol
ONVO
Industry

Key metrics

Basic
Market capitalization
$6.1m
Enterprise Value
$5.2m
Net debt
positive
Cash
$1.2m
Shares outstanding
1.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
50.7 | 35.1
EV/Sales
43.2 | 29.9
EV/FCF
negative
P/B
16.9
Financial Health
Equity Ratio
56.7%
Return on Equity
-407.4%
ROCE
-1,395.3%
ROIC
-820.9%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$120.0k | $173.4k
EBITDA
$-12.3m | -
EBIT
$-12.6m | $-15.6m
Net Income
$-12.4m | $-1.1m
Free Cash Flow
$-10.1m
Growth (TTM | estimate)
Revenue
-52.0% | 57.6%
EBITDA
37.1% | -
EBIT
36.5% | -3.5%
Net Income
35.1% | 92.4%
Free Cash Flow
40.3%
Margin (TTM | estimate)
Gross
72.1%
EBITDA
-10,067.2% | -
EBIT
-10,293.4%
Net
-10,151.6% | -647.7%
Free Cash Flow
-8,286.9%
More
EPS
$-0.7
FCF per Share
$-7.1
Short interest
4.1%
Employees
-
Rev per Employee
-
Show more

Is Organovo Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Organovo Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Organovo Holdings, Inc. forecast:

4x Hold
57%
3x Sell
43%

Analyst Opinions

7 Analysts have issued a Organovo Holdings, Inc. forecast:

Hold
57%
Sell
43%

Financial data from Organovo Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
0.12 0.12
52% 52%
100%
- Direct Costs 0.01 0.01
-
8%
0.09 0.09
-
75%
- Selling and Administrative Expenses 7.40 7.40
27% 27%
6,167%
- Research and Development Expense 5 5
48% 48%
4,167%
-12 -12
37% 37%
-10,233%
- Depreciation and Amortization 0.28 0.28
4% 4%
233%
EBIT (Operating Income) EBIT -13 -13
37% 37%
-10,465%
Net Profit -12 -12
35% 35%
-10,325%

In millions USD.

Don't miss a Thing! We will send you all news about Organovo Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Organovo Holdings, Inc. Stock News

Neutral
GlobeNewsWire
3 months ago
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.
Neutral
GlobeNewsWire
3 months ago
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.
Neutral
GlobeNewsWire
4 months ago
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today reported preliminary unaudited cash for the fiscal year ending March 31, 2025, and net cash utilization results for the fiscal fourth quarter of 2025....
More Organovo Holdings, Inc. News

Company Profile

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

Head office United States
CEO Keith Murphy
Founded 2012
Website organovo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today